I
INNOVATIVE PHARMACEUTICAL BIOTECH LTD
HKEX: 0399 (STARCOIN GROUP)
Last update: 15 hours ago0.162
-0.01 (-7.95%)
| Previous Close | 0.176 |
| Open | 0.178 |
| Volume | 27,640,000 |
| Avg. Volume (3M) | 37,393,839 |
| Market Cap | 347,131,584 |
| Price / Sales | 142.41 |
| 52 Weeks Range |
| Operating Margin (TTM) | 657.78% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | -18.70% |
| Quarterly Earnings Growth (YOY) | -47.50% |
| Total Debt/Equity (MRQ) | 4,140.48% |
| Current Ratio (MRQ) | 0.010 |
| Operating Cash Flow (TTM) | -6.53 M |
| Levered Free Cash Flow (TTM) | -128.15 M |
| Return on Assets (TTM) | -0.67% |
| Return on Equity (TTM) | -330.85% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Retail (HK) | Mixed | Mixed |
| Specialty Retail (Global) | Mixed | Mixed | |
| Stock | STARCOIN GROUP | - | - |
AIStockmoo Score
-1.0
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.5 |
| Average | -1.00 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| STARCOIN GROUP | 347 M | - | - | - |
| SA SA INT'L | 2 B | 4.17% | 19.33 | 1.73 |
| GOME RETAIL | 766 M | - | 0.320 | 0.210 |
| IH RETAIL | 505 M | 10.67% | 11.83 | 0.600 |
| BONJOUR HOLD | 213 M | - | - | 0.600 |
| DAOHE GLOBAL | 98 M | - | 6.50 | 0.800 |
|
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong. |
|
| Sector | Consumer Cyclical |
| Industry | Specialty Retail |
| Investment Style | Small Value |
| % Held by Insiders | 42.28% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |